<DOC>
	<DOCNO>NCT00005862</DOCNO>
	<brief_summary>Phase II trial study effectiveness SU5416 treat patient advance , metastatic , recurrent soft tissue sarcoma . SU5416 may stop growth soft tissue sarcomas stop blood flow tumor .</brief_summary>
	<brief_title>SU5416 Treating Patients With Advanced , Metastatic , Recurrent Soft Tissue Sarcomas</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , response duration , overall survival patient advance , metastatic , recurrent soft tissue sarcoma gastrointestinal stromal tumor treat SU5416 . II . Determine safety SU5416 patient . OUTLINE : This multicenter study . Patients receive SU5416 IV twice weekly 4 week . Treatment continue every 4 week absence disease progression unacceptable toxicity . Patients follow monthly 3 month every 3 month 1 year .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Semaxinib</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm advanced , metastatic , recurrent , unresectable soft tissue sarcoma gastrointestinal stromal tumor Measurable disease define lesion measure least one dimension least 20 mm conventional technique least 10 mm spiral CT scan Must receive prior chemotherapy response progression initial response Evidence disease progression past 3 month No CNS metastases primary brain tumor PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : At least 12 week WBC great 2,000/mm3 Platelet count great 100,000/mm3 Fibrin split product great 0.001 mg Fibrinogen great 200 mg/dL Bilirubin great upper limit normal ( ULN ) AST/ALT le 1.5 time ULN PT/PTT less 1.25 time ULN Creatinine great 1.5 mg/dL At least 1 year since bypass surgery atherosclerotic coronary artery disease No uncompensated coronary artery disease No history myocardial infarction unstable/severe angina past 6 month No severe peripheral vascular disease No history deep venous arterial thrombosis past 3 month No history pulmonary embolism past 3 month Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No diabetes mellitus No history bleed diathesis No known active retroviral disease No AIDSassociated Kaposi 's sarcoma No history allergic reaction Cremophor paclitaxel No uncontrolled illness psychiatric disorder would preclude study PRIOR CONCURRENT THERAPY : No concurrent immunotherapy At least 3 week since prior chemotherapy ( 6 week since mitomycin nitrosoureas ) No concurrent chemotherapy At least 3 week since prior radiotherapy No concurrent radiotherapy Greater 2 week since prior minor surgery ( great 4 week since major surgery ) No concurrent antiinflammatory drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2002</verification_date>
	<keyword>stage III adult soft tissue sarcoma</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>gastrointestinal stromal tumor</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
</DOC>